toll-like receptor
Showing 1 - 25 of >10,000
Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)
Completed
- Testicular Torsion and TLR 4 Was Investigated
- Toll-like receptor 4
- (no location specified)
Sep 23, 2022
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like
Recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Irreversible Electroporation (IRE)
- +2 more
-
Amsterdam, North-Holland, NetherlandsAmsterdam University Medical Centre (location VUmc)
Dec 18, 2022
Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)
Not yet recruiting
- Spondylitis
- Tuberculosis
- 400 IU
- +3 more
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
May 11, 2022
HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)
Recruiting
- HIV Infections
- HIVIS DNA/MVA-CMDR
- +2 more
-
Tygerberg Hills, Cape Town, South AfricaStellenbosch University
Apr 20, 2022
Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])
Withdrawn
- Hepatitis B
- Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
-
Baltimore, Maryland
- +1 more
Jul 19, 2022
Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)
Completed
- Melanoma
- gp100
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 20, 2021
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
Recruiting
- Complication of Prematurity
- Immunologic Deficiency Syndromes
- Adjuvant
- Blood Collection
-
Gainesville, FloridaUF Health
Nov 4, 2021
Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- entolimod
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 20, 2022
Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)
Completed
- Breast Cancer
- +2 more
- Radiation
- +2 more
-
New York, New YorkNew York University Medical Center
Oct 25, 2021
The Effect of Human Prostate Tissue on Platelet Activation
Completed
- Prostate Hyperplasia
- +2 more
- (no location specified)
Sep 19, 2021
Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)
Withdrawn
- Itch
- Zyclara 3.75 % Topical Cream
- +5 more
-
Aalborg, Nordjylland, DenmarkAalborg University
Jan 13, 2021
Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +2 more
- Nivolumab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Dec 16, 2021
Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)
Completed
- Head and Neck Squamous Cell Carcinoma
- +10 more
- Durvalumab
- +2 more
-
Atlanta, Georgia
- +6 more
Mar 1, 2022
Tumors or Premalignant Lesions Trial in Leiden (Hespecta)
Completed
- Tumors or Premalignant Lesions
- Hespecta
-
Leiden, NetherlandsLeiden University Medical Center
Feb 17, 2021
Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)
Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)
Withdrawn
- Glioblastoma
- Glioma
- Bevacizumab
- +3 more
-
New York, New YorkNYU Perlmutter Cancer Center
Jan 8, 2020
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1
Not yet recruiting
- Overweight and Obesity
- 24-hour ambulatory blood pressure
- Liberal salt diet
- (no location specified)
Oct 4, 2023
Preoperative Prandial State of Patients Taking Glucagon-Like
Recruiting
- Pulmonary Aspiration
- Gastric ultrasound
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 6, 2023
Glucagon-like Peptide 1 Receptor Agonists and Mental Health
Not yet recruiting
- Diabetes Mellitus
- +2 more
- GLP-1 receptor agonist
- (no location specified)
Aug 4, 2022
Periodontal Inflammation Trial in Ajman (saliva analysis for Toll like receptor activity)
Completed
- Periodontal Inflammation
- saliva analysis for Toll like receptor activity
-
Ajman, Dubai, United Arab EmiratesAjman University
Dec 16, 2019
Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in
Recruiting
- Lymphomas Non-Hodgkin's B-Cell
- +5 more
- WZTL002-1 (1928T2z CAR-T cells)
- Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
-
Wellington, New ZealandWellington Hospital, Capital & Coast District Health Board
Feb 18, 2020